Tag Archives: AstraZeneca Covishield

Embassy of India, Muscat has informed that the Government of the Sultanate of Oman has added Covaxin to the approved list of COVID-19 vaccines for travel to Oman. The Civil Aviation Authority issued a notification on 27th October regarding this. All passengers from India who have received two doses of Covaxin at least 14 days before the estimated arrival date will now be able to travel to Oman without the requirement of quarantine. All other COVID-19 related requirements/conditions, such as pre-arrival RT-PCR test shall be applicable for such passengers. This notification will significantly ease travel to Oman for Indian nationals who have taken Covaxin, Passengers, who have taken AstraZeneca/Covishield are already permitted to travel to Oman without quarantine.

UK has given a nod for Covishield being accepted as approved vaccine for inbound travellers to the country. Under a new set of guidelines, UK Govt has accepted a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in some countries. “Formulations of the 4 listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, qualify as approved vaccines,” it said. The guideline says, “From 4am Monday 4 October, you will qualify as fully vaccinated if you are vaccinated either under an approved vaccination programme in the UK, Europe, USA or UK vaccine programme overseas or with a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea, Taiwan or the United Arab Emirates (UAE). You must have had a complete course of an approved vaccine at least 14 days before you arrive in England.”